JPMorgan Chase & Co. vs Novartis AG
JPMorgan Chase & Co. is worth $947.643B, 3.2× the $299.439B market cap of Novartis AG. Updated daily.
| Metric | Novartis AGNVS  | |
|---|---|---|
| Market cap | $947.643B | $299.439B |
| Global rank | #1 | #2 |
| Share price | $356.50 | $157.54 |
| Change | -1.53% | +1.90% |
| Revenue | $181.847B | $56.674B |
| Net income | $57.048B | $13.984B |
| Country | United States | Switzerland |
| Sector | Financial Services | Healthcare |
Want a wider comparison? Compare up to five companies.
Related comparisons
Frequently asked questions
- Is JPMorgan Chase & Co. bigger than Novartis AG?
- JPMorgan Chase & Co. has a market cap of $947.643B against $299.439B for Novartis AG, making it 3.2 times as valuable.
- Which company earns more, JPM or NVS?
- JPMorgan Chase & Co. reported net income of $57.048B and Novartis AG reported $13.984B in their most recent annual periods.